401 Odcinki

  1. Episode 343: ESMO 2024 - TiNivo-2 Trial

    Opublikowany: 14.09.2024

  2. Episode 342: ESMO 2024 Preview with Silke Gillessen

    Opublikowany: 3.09.2024

  3. Episode 341: Hormone Resistance in Prostate Cancer

    Opublikowany: 27.08.2024

  4. Episode 340: Cancer Immunity Cycle Update

    Opublikowany: 19.08.2024

  5. Episode 339: Tres Uramigas analizan lineamientos de ESMO para GU

    Opublikowany: 9.08.2024

  6. Episode 338: RCC: Debulking Nephrectomy, Adjuvant Therapy Future and More

    Opublikowany: 6.08.2024

  7. Episode 337: Updated NCCN Guidelines in RCC

    Opublikowany: 30.07.2024

  8. Episode 336: Which patients are not suitable for 1st line EVP in bladder cancer

    Opublikowany: 24.07.2024

  9. Episode 335: Novel immune therapies for renal cancer

    Opublikowany: 19.07.2024

  10. Episodio 334 en español: Tres Uramigas ASCO 2024

    Opublikowany: 11.07.2024

  11. Episode 333: The Uromigos Cup - The Netherlands

    Opublikowany: 5.07.2024

  12. Episode 332: The Uromigos Cup - Germany's Entry

    Opublikowany: 26.06.2024

  13. Episode 331: AUA 2024 NMIBC Highlights

    Opublikowany: 21.06.2024

  14. Episode 330: ASCO 2024 Highlights

    Opublikowany: 10.06.2024

  15. Episode 329: Japan in the Uromigos Cup qualifying round

    Opublikowany: 7.06.2024

  16. Episode 328 ASCO24: Emergency podcast - what the NADINA trial means for preoperative GU cancer studies

    Opublikowany: 5.06.2024

  17. Episode 327 ASCO24: CM901 and EV302 Efficacy and QOL Updates

    Opublikowany: 4.06.2024

  18. Episode 326 ASCO24: KIM-1 in Renal Cancer

    Opublikowany: 3.06.2024

  19. Episode 325 ASCO24: KN426 and the CLEAR trial - tissue based biomarkers for kidney cancer

    Opublikowany: 3.06.2024

  20. Episode 324 ASCO24: SURE1 neoadjuvant sacituzumab govitecan in UC

    Opublikowany: 2.06.2024

4 / 21

Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

Visit the podcast's native language site